A preprint titled “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19” is out detailing a meta-analysis of published research papers on ivermectin’s efficacy. The authors come from reputable institutions like The University of Texas Health Science Center and the Eastern Virginia Medical School, so I consider their analysis to be trustworthy. The link: https://osf.io/wx3zn/
By analyzing existing studies, they found ivermectin is;
a. 60% effective in late treatment,
b. 91% effective in early treatment,
c. 98% effective in pre-exposure prophylaxis, and
d. 87% effective in post-exposure prophylaxis.
The studies show a p value that there is only a combined 1 in 2 million chance that the data about ivermectin’s effectiveness is in error. So it should be used in common practice.
Here is a video where Dr, Chris Martenson reviews the study and component studies and gives his analysis. I encourage everyone to watch it, and for medical professionals to read the papers too. https://youtu.be/z5-S49EqCJ8
I encourage anyone who is at high risk of exposure, already exposed, or has contracted the SARS-COV 2 virus to consult with their doctor about whether ivermectin is a prophylactic or treatment option for you. As Dr. Martenson discusses it has also been shown to be effective for those with long-term lingering symptoms.
Ivermectin is readily available and inexpensive and is commonly used as an antiparasitic in humans and animals. It is known to be safe at standard doses. Early on it was found to kill the sars-cov 1 and 2 and other viruses in-vitro, and follow-up studies have shown that it can be as much as 90% effective in treating covid-19 in humans including significant death rate reduction for hospitalized patients. While ivermectin for veterinary applications may be available without prescription, self-administration is not recommended.
Please share the links with your doctors, friends and loved ones.